v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 1,220,327 445,402
Sales and marketing 50,950 57,016
Depreciation and amortization 70,767 29,703
General and administrative 1,932,690 1,854,684
Total operating expenses 3,274,734 2,386,805
Loss from operations (3,274,734) (2,386,805)
Other (expense) income:    
Interest expense 0 (822,858)
Interest income 4,231 1,318
Total other income (expense) 4,231 (821,540)
Net loss (3,270,503) (3,208,345)
Dividend to Series A and B preferred stockholders 0 (160,219)
Net loss attributable to common stockholders $ (3,270,503) $ (3,368,564)
Net loss per common share, basic and diluted (in dollars per share) $ (0.19) $ (0.43)
Weighted average number of common shares outstanding, basic and diluted (in shares) 16,781,210 7,745,378

Source